PIN1 and neoplasm: As an independent approach to demonstrate that ATO has anticancer activity by targeting Pin1 oncogenic function and cooperating with ATRA, we chose to study TICs/CSCs of TNBCs, which are a proposed source of tumor initiation, growth, and metastasis, but are not effectively targeted by current cancer drugs4,5.